Cardiology (all articles)
Bicuspid aortic valve stenosis: from pathophysiological mechanism, imaging diagnosis, to clinical treatment methods.
10 Aug, 2022 | 12:22h | UTC
Changes to the European Resuscitation Council guidelines for adult resuscitation.
9 Aug, 2022 | 12:50h | UTCChanges to the European Resuscitation Council guidelines for adult resuscitation – BJA Education
Related:
2021 Resuscitation Guidelines – Resuscitation Council UK
Systematic Review | Smoking cessation for secondary prevention of cardiovascular disease.
9 Aug, 2022 | 12:42h | UTCSmoking cessation for secondary prevention of cardiovascular disease – Cochrane Library
Is the contemporary care of older persons with acute coronary syndrome evidence-based?
8 Aug, 2022 | 11:48h | UTC
Commentary from the author on Twitter
♦️Heart disease leading cause of death in older adults
♦️Less likely to receive guideline recommended treatment
♦️Frailty, multi-morbidity linked to worse outcomes
♦️We explore this in our manuscript led by @GregBMills1
💥Open access for free download😊https://t.co/l452O1QJTJ pic.twitter.com/HCRuwle3KK— Professor Vijay Kunadian (@VijayKunadian) January 29, 2022
Cohort Study | Age at menopause and risk of heart failure and atrial fibrillation.
5 Aug, 2022 | 14:38h | UTCAge at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study – European Heart Journal (link to abstract – $ for full-text)
Editorial: Premature menopause and cardiovascular disease: can we blame estrogen? – European Heart Journal
News Release: Premature menopause is associated with increased risk of heart problems – European Society of Cardiology
RCT | Effect of lifestyle coaching or enhanced pharmacotherapy on blood pressure control among black adults with persistent uncontrolled hypertension.
5 Aug, 2022 | 13:52h | UTCCommentary: Lifestyle Coaching Intervention Improves BP Control Among Blacks – HealthDay
Commentary on Twitter
In this cluster randomized trial, a 1-year lifestyle coaching intervention (but not enhanced pharmacotherapy) was more effective than usual care in achieving blood pressure control at 2-4 years in Black adults with persistent uncontrolled hypertension. https://t.co/c7pZykQnFw
— JAMA Network Open (@JAMANetworkOpen) May 18, 2022
Standardized definitions for bioprosthetic valve dysfunction following aortic or mitral valve replacement.
4 Aug, 2022 | 14:35h | UTC
Commentary on Twitter
Standardized Definitions for Bioprosthetic Valve Dysfunction Following Aortic or Mitral Valve Replacement: JACC State-of-the-Art Reviewhttps://t.co/xaUpRTD0rd@JACCJournals pic.twitter.com/IINRrOtXRY
— Giuseppe Biondi-Zoccai (@gbiondizoccai) July 26, 2022
Under a http://creativecommons.org/licenses/by/4.0/ license
In a cohort study with a median follow‐up of 23.2 years, both very low and very high LDL‐C levels are associated with increased risk of cardiovascular mortality in the general population.
4 Aug, 2022 | 14:25h | UTC
M-A | The outcome of post-cardiotomy extracorporeal membrane oxygenation in neonates and pediatric patients.
4 Aug, 2022 | 13:48h | UTC
Cohort Study | Association between gout flare and subsequent cardiovascular events among patients with gout.
3 Aug, 2022 | 14:30h | UTCAssociation Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout – JAMA (free for a limited period)
Editorial: Cardiovascular Events and Gout Flares – JAMA (free for a limited period)
News Release: Flare-ups of gout are linked to heart attack and stroke – University of Nottingham
Commentary: Association Between Gout Flare and Subsequent Cardiovascular Events – American College of Cardiology
Deep learning electrocardiographic analysis for detection of left-sided valvular heart disease.
3 Aug, 2022 | 14:19h | UTC
Commentary from the author on Twitter (thread – click for more)
Out today in @JACCJournals, our ValveNet study shows a ML model can detect mod-severe left sided valve disease from ECG. This model is currently running live in our health system daily. Now let me tell you everything wrong with it! A brief 🧵 https://t.co/rjtZxxTLt9 pic.twitter.com/oZKDDnZqYU
— Pierre Elias, MD (@PierreEliasMD) August 1, 2022
RCT | Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction.
3 Aug, 2022 | 14:06h | UTC
Commentary on Twitter
No one wants to add meds just so you can add more meds. BUT, adding patiromer in select patients with HFrEF so you can optimize GDMT sure is compelling… 🤔 https://t.co/79gSEwon4y
— ATRIUM Cardiology (@ATRIUMRx) July 29, 2022
Cohort Study | Association between early left ventricular ejection fraction improvement after transcatheter aortic valve replacement and 5-year clinical outcomes.
3 Aug, 2022 | 13:58h | UTCAssociation Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes – JAMA Cardiology (link to abstract – $ for full-text)
Commentary: Early LV Recovery After TAVI Points to Better 5-Year Survival – TCTMD
Commentary on Twitter
In patients with severe #aorticstenosis and left ventricular ejection fraction (LVEF) less than 50%, 1 in 3 experience LVEF improvement within 1 month after TAVR. Early LVEF improvement is associated with lower 5-year all-cause and cardiac death. https://t.co/81H6roA8nV
— JAMA Cardiology (@JAMACardio) July 27, 2022
Retrospective Cohort Study | Syncope and the risk of subsequent motor vehicle crash.
2 Aug, 2022 | 12:33h | UTCSyncope and the Risk of Subsequent Motor Vehicle Crash: A Population-Based Retrospective Cohort Study – JAMA Internal Medicine (free for a limited period)
Editorial: Driving Safety After an Acute Illness—This Is Our Lane – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
"I fainted…am I safe to drive?" Study found that 9,223 drivers with an ED visit for syncope had subsequent crash risks no different than controls, suggesting more stringent driving restrictions might not be justified. https://t.co/T0GUJ63Nci
— JAMA Internal Medicine (@JAMAInternalMed) August 1, 2022
Position Paper | Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices.
2 Aug, 2022 | 12:15h | UTC
Cohort Study | Long-term leisure-time physical activity intensity and all-cause and cause-specific mortality.
1 Aug, 2022 | 12:26h | UTCLong-Term Leisure-Time Physical Activity Intensity and All-Cause and Cause-Specific Mortality: A Prospective Cohort of US Adults – Circulation (free for a limited period)
News Release: New study finds lowest risk of death was among adults who exercised 150-600 minutes/week – American Heart Association
Perspective | Aspirin for the primary prevention of atherosclerotic cardiovascular disease in women.
1 Aug, 2022 | 12:25h | UTCAspirin for the Primary Prevention of Atherosclerotic Cardiovascular Disease in Women – JAMA (free for a limited period)
Guidelines | Peri-operative management of people with cardiac implantable electronic devices.
1 Aug, 2022 | 12:39h | UTC
Review | Advances in percutaneous patent foramen ovale closure: from the procedure to the echocardiographic guidance.
1 Aug, 2022 | 12:14h | UTC
Global burden of rheumatic heart disease: trends from 1990 to 2019.
1 Aug, 2022 | 12:07h | UTCGlobal burden of rheumatic heart disease: trends from 1990 to 2019 – Arthritis Research & Therapy
Commentary: Death, disability from rheumatic heart disease decreased globally from 1990 to 2019 – Healio (free registration required)
Review | Management of heart failure in patients with chronic kidney disease.
1 Aug, 2022 | 11:59h | UTCManagement of Heart Failure in Patients with Chronic Kidney Disease – European Cardiology Review
M-A | Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes.
29 Jul, 2022 | 12:37h | UTCCommentaries:
No justification for bespoke antihypertensive intervention in type 2 diabetes – medwire News
Blood pressure control according to type 2 diabetes status – The Lancet Diabetes & Endocrinology (free registration required)
Commentary on Twitter
Online—Blood pressure-lowering treatment for prevention of major #cardiovascular diseases in people with and without type 2 #diabetes: an individual participant-level data meta-analysis https://t.co/AmNxyW9Via #T2D #BloodPressure #hypertension #openaccess pic.twitter.com/NfdLktZXai
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) July 25, 2022
Position Paper | Red yeast rice for dyslipidemias and cardiovascular risk reduction.
29 Jul, 2022 | 12:35h | UTC
Systematic Review | Antiplatelet agents and anticoagulants for hypertension.
29 Jul, 2022 | 12:29h | UTCAntiplatelet agents and anticoagulants for hypertension – Cochrane Library
Summary: Antiplatelet agents and anticoagulants for high blood pressure – Cochrane Library
Commentary on Twitter
Do #antiplatelet agents & #anticoagulants improve outcomes in people with #hypertension?
Our newly updated @CochraneLibrary review looks at the evidence of 6 RCTs involving more than 61,000 participants: https://t.co/zaXP4YLg4n#CochraneEvidence #blogshot pic.twitter.com/X1DK2NTCtb
— Cochrane Hypertension (@CochraneHTN) July 28, 2022
Cohort Study | Impact of peridevice leak on 5-year outcomes after left atrial appendage closure.
29 Jul, 2022 | 12:26h | UTCImpact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure – Journal of the American College of Cardiology (link to abstract – $ for full-text)
Commentary: Peridevice Leaks After LAA Occlusion Signal Poorer 5-Year Outcomes – TCTMD